the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese

Annual Information Service

EPiQ Market Intelligence Program: Pancreatic Cancer

Published by WWMR, Inc. Contact us : +1-860-674-8796
Published Issues / Year: 2 Content info  
Product code WW24417
Price From  US $ 17500 Order/Price list
US $ 17500 Hard Copy, PDF by E-mail, Excel appendices, (Corporate Use License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

The first and only pancreatic cancer market intelligence program to be based on the review of over 500 longitudinal patient charts.

  • Longitudinal patient and physician tracking over 3 years
  • Actual clinical activity captured from patient charts, not physician recall
  • Patient segmentation by type of pancreatic cancer and line of drug therapy

WWMR expert analysis includes:

  • Qualitative analysis of nearly 100 current and future drug treatments
  • Thought leader opinions on key unmet medical needs and clinical potential for new mechanisms of action
  • Comprehensive review of clinical literature and industry developments

Program Features:

  • Monthly drug treatment data by type of pancreatic cancer (exocrine and endocrine) and line of therapy, January 2001 to January 2004
  • Semi-annual data updates through June 2005
  • Drug-treated patient forecasts by patient segment - endocrine and exocrine patients by stage, through 2013
  • Market forecasts by drug class, through 2013
  • Product-by-product evaluations of investigational agents
  • Incidence, prevalence, and mortality forecasts, through 2013
  • Quantitative treatment trend analysis
  • Unmet needs analysis
  • Disease and current treatment review

Program Benefits:

  • Pinpoint the specific patient segments that have high market potential in the next 10 years
  • Compare the epidemiology, current treatment patterns, patient demographics, and drug-treated population forecasts by patient segment
  • Target specific patient segments that will benefit most from drugs in the pipeline
  • Anticipate upcoming competitors and product licensing opportunities
  • Recognize the impact of unique market dynamics - including the potential off-label usage - on product uptake forecasts
  • Develop patient segment-specific and drug class-specific forecasts for the overall market and for key patient segments
  • Understand the characteristics of patients unmet need

Program Deliverables:

  • Fully-referenced color report
  • Comprehensive interactive appendix
  • Semi-annual data updates
Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.